Income StatementBalance SheetCash FlowSegments
Agilent Technologies logo

Agilent Technologies Cash Flow Statement

Operating, investing, and financing cash movements

Agilent Technologies generated $1.4B in operating cash flow over the trailing twelve months. After $403.0M in capital expenditures, free cash flow was $993.0M. Free cash flow decreased 0.2% year-over-year. Based on the Q4 2025 filing.

Net Cash From Operating (TTM)$1.4BNet Cash From Investing (TTM)-$393.0MNet Cash From Financing (TTM)-$757.0MCapital Expenditures (TTM)$403.0MDepreciation And Amortization Cf (TTM)$283.0MNet Change In Cash (TTM)$290.0M
Latest FilingQ4 2025
Report Date2026-03-03
Market Cap$32.0B
P/E Ratio24.81
ROE19.95%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Stemcentrx Impairment Charge$4.8M$3.8M$3.8M$3.8M$3.8M—
Inventory write-down$12.0M$10.0M$12.0M$8.0M$15.0M$10.0M
Other non-cash income (expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Other non-cash income (expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Change in accounts payable$25.0M$3.0M-$30.0M$14.0M$29.0M$39.0M
Change in accounts receivable—$30.0M-$3.0M$17.0M$105.0M$18.0M
Change in accrued liabilities—-$104.0M$79.0M-$1.0M$95.0M-$151.0M
Change in inventories-$19.0M$40.0M$1.0M$31.0M$25.0M$39.0M
Other working capital changes—-$173.0M$187.0M$47.0M-$91.0M$11.0M
Gain (Loss) on Investment in Cenovus Energy$0.0$1.0M-$28.0M-$1.0M-$8.0M$2.0M
Deferred income taxes-$56.0M-$10.0M-$18.0M-$7.0M-$95.0M$25.0M
Depreciation and amortization$69.0M$72.0M$73.0M$72.0M$71.0M$67.0M
Net gains (losses) on investments$0.0$1.0M-$28.0M-$1.0M-$8.0M$2.0M
Other Non-Cash Income (Expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Other Non-cash Income (Expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Other Non-cash Income (Expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Net cash from operating activities$481.0M$431.0M$221.0M$362.0M$545.0M$268.0M
Net income$351.0M$318.0M$215.0M$336.0M$434.0M$305.0M
Other non-cash income (expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Equity Securities, FV-NI, Gain (Loss)$0.0$1.0M-$28.0M-$1.0M-$8.0M$2.0M
Gain on sale of business and assets$0.0$0.0$0.0$0.0$0.0—
Accrued compensation and employee benefits—-$104.0M$79.0M-$1.0M$95.0M-$151.0M
Other current liabilities$2.3M$2.8M$2.8M$2.8M$2.8M—
Inventory write-downs$12.0M$10.0M$12.0M$8.0M$15.0M$10.0M
Other Noncash Income (Expense)$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Proceeds From Sale Of Notes Receivable$0.0$500.0K$500.0K$500.0K$500.0K—
Other Non-cash Income and Expense$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Gain Associated with Juice Transaction$0.0$0.0$0.0$0.0$0.0—
Other Non-Cash Adjustments$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Other Non-Cash Income and Expense$3.0M$0.0-$2.0M-$2.0M-$1.0M-$2.0M
Impairment of Goodwill and Other Intangibles$4.8M$3.8M$3.8M$3.8M$3.8M—
Stock-based compensation$26.0M$40.0M$30.0M$32.0M$26.0M$41.0M
Inventory and Purchase Commitments Write-downs$12.0M$10.0M$12.0M$8.0M$15.0M$10.0M
Loss on Sale of Subsidiary$0.0$0.0$0.0$0.0$0.0—

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$859.0M-$4.0M$0.0$0.0$0.0$0.0
Capital expenditures$93.0M$97.0M$114.0M$103.0M$93.0M$93.0M
Payments to notes receivables$2.0M$1.0M$0.0$0.0$0.0$0.0
Net cash from investing activities-$954.0M-$94.0M-$114.0M-$96.0M-$90.0M-$93.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$1.2B$4.0M$0.0$0.0$0.0$0.0
Repayments of debt$420.0M$1.0M$0.0$1.0M$1.0M$2.0M
Dividends paid$68.0M$71.0M$70.0M$71.0M$70.0M$72.0M
Payments of Ordinary Dividends—$71.0M$70.0M$71.0M—$72.0M
Proceeds from exercises of stock options and other stock issuances$1.0M$30.0M$1.0M$29.0M$12.0M$31.0M
Proceeds from (Repayments of) Short-Term Debt—-$30.0M$130.0M-$87.0M-$55.0M$0.0
Net cash from financing activities$0.0-$180.0M-$116.0M-$219.0M-$200.0M-$222.0M
Proceeds from issuance of common stock$1.0M$30.0M$1.0M$29.0M$12.0M$31.0M
Repurchases of common stock$335.0M$90.0M$165.0M$85.0M$85.0M$152.0M
Net change in short-term borrowings—-$30.0M$130.0M-$87.0M-$55.0M$0.0
Taxes paid for net share settlement$3.0M$22.0M$2.0M$4.0M$1.0M$27.0M
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries—-$30.0M$130.0M-$87.0M-$55.0M$0.0

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$388.0M$334.0M$107.0M$259.0M$452.0M$175.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$2.0M-$19.0M$28.0M$1.0M—$16.0M
Net increase (decrease) in cash-$450.0M$138.0M$19.0M$48.0M$254.0M-$31.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$30.0M$19.0M$229.0M$56.0M$14.0M$105.0M
Interest paid$30.0M$3.0M$48.0M$4.0M$46.0M$1.0M
Income Taxes Paid, Net$30.0M$19.0M$229.0M$56.0M$14.0M$105.0M